UNSPSC 51282423: Piperacillin sodium

This classification denotes an extended spectrum penicillin antibiotic with the molecular formula C23H26N5O7S.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M98T69Q7HP, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((((4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl)amino)phenylacetyl)amino)-3,3-dimethyl-7-oxo-, monosodium salt, (2s-(2alpha,5alpha,6beta(s*)))- but more generally known as piperacillin sodium, which bears US NIH Compound Identifier 43066.

UNSPSC 51282423 Piperacillin sodium is a Commodity code that in recent state and local solicitations maps to a broader pharmaceutical and medical supply procurement activity rather than piperacillin-specific acquisitions. State and local governments use this code to tag purchases of generic pharmaceuticals, over-the-counter products, and emergency medical supplies. The issuing bodies include county health departments, municipal fire and rescue services, state health and human services commissions, and cooperative purchasing alliances serving multiple jurisdictions. Recent solicitations show demand for medical and first aid supplies, naloxone and drug deactivation systems, and generic multi-source pharmaceuticals through authorized wholesaler networks. The scope of work encompasses competitive bidding for consumable medical products with quarterly or annual delivery cycles, compliance with FDA and cGMP standards, expiration-date requirements, and integration with existing pharmacy benefit manager or direct-to-manufacturer contracting arrangements.

Recent activity spans Florida, Texas, and Minnesota. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 drug deactivation systems annually with a response deadline of July 26, 2023. The City of Tampa's Purchasing Department released ITB 26P00145 in March 2026 for medical and first aid supplies to the Tampa Fire Department Rescue Division—an estimated $700,000 contract designated as a sheltered market opportunity for certified Small Local Business Enterprises with a 5 percent bid discount. The Minnesota Department of Administration's Office of State Procurement, administering the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), posted an RFP for generic multi-source pharmaceuticals and OTC products in January 2026 with a response deadline of March 26, 2026, requiring vendors to supply through three authorized wholesalers and comply with DSCSA and cGMP standards. The Texas Health and Human Services Commission issued RFI HHS0017013 in April 2026 to explore direct-to-manufacturer prescription programs outside existing PBM arrangements, signaling emerging state interest in alternative pharmaceutical distribution models.